Health Care Equipment & Services

Edwards Lifesciences’ recent executive share sales reveal routine portfolio moves, not a shift in strategy, as the company continues to boost transcatheter valve access, cost‑effective outcomes and global market growth.

Intuitive Surgical’s insider sales, DCF‑based over‑valuation, and decade‑long share‑price surge show a high‑growth, low‑leverage robot‑surgery firm poised for future gains.

Medtronic’s planned spin‑off of its MiniMed unit seeks to unlock shareholder value, sharpen focus on core medical devices, and adapt to the high‑margin digital health market.

Siemens Healthineers sees a modest share‑price lift amid a sluggish European market, driven by medical‑technology optimism, strong R&D, and value‑based pricing.

UnitedHealth’s stock dips near a 52‑week low, yet its earnings momentum, margin expansion, and cost‑pressure management suggest undervaluation and long‑term growth potential.

Explore how German healthcare stocks like Fresenius Medical Care stay resilient amid oil‑price swings and geopolitical uncertainty, with insights on reimbursement models, tech investment, and operational strategies.

Sonova’s share rally reflects strong hearing‑aid profits, high R&D spend and ESG moves, yet supply‑chain risks and regulatory shifts could curb growth.

Discover why Stryker Corp’s $105 B market cap, high‑margin orthopedics, and supply‑chain resilience make it a top long‑term medical‑technology investment.

Dexcom announces COO promotion of CFO Jereme Sylvain and details routine insider sales, highlighting leadership shifts and regulatory transparency.

Zimmer Biomet’s stock has slid steeply over three years, erasing early gains. Discover why the equity’s decline matters for investors and what it signals.